Wu et al. developed a PPSG system co-loaded with the antitumor agent pirarubicin (THP) and the cyclooxygenase-2 (COX-2) inhibitor celecoxib (CXB), which inhibits the postoperative recurrence and metastasis of breast cancer (Figure 7) [81]. This evidence concerns the gene PTGS2 and breast carcinoma.